Up-to-date Information for Investors
On this page you will find current capital market announcements and ad hoc news from Hoenle AG.
1/2
Capital Market Release
- 10.Dec.2025 PTA-DD: Hoenle AG: Managers’ transactions announcement according to article 19 MAR
- 08.Dec.2025 PTA-News: Hoenle AG: Hoenle Group improved its operating profit before depreciation to EUR 5.8 million in the 2024/25 financial year
- 09.Oct.2025 PTA-AFR: Hoenle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 14.Sep.2025 PTA-News: Dr. Hönle AG: Dr. Franz Richter replaces Dr. Markus Arendt on the Management Board of Hoenle AG
- 07.Aug.2025 PTA-News: Dr. Hönle AG: Hoenle Group achieves EBITDA of EUR 3.6 million with EUR 69.8 million in sales after nine months
- 08.May.2025 PTA-News: Dr. Hönle AG: Business activity picks up in the second quarter
- 25.Feb.2025 PTA-News: Dr. Hönle AG: Hoenle Group starts new financial year as planned and confirms outlook for full financial year
- 17.Feb.2025 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 12.Feb.2025 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 12.Feb.2025 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 06.Feb.2025 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 02.Jan.2025 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 02.Jan.2025 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 06.Dec.2024 PTA-News: Dr. Hönle AG: Hönle Group achieves a balanced operating result with sales of €98.7 million in the 2023/24 financial year
- 20.Nov.2024 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 07.Aug.2024 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 07.Aug.2024 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 07.Aug.2024 PTA-News: Dr. Hönle AG: Hönle achieves almost balanced operating result in a challenging market environment after 9 months
- 06.Aug.2024 PTA-News: Dr. Hönle AG: Robert Stark set to be new CFO of Dr. Hönle AG
- 08.May.2024 PTA-News: Dr. Hönle AG: Sales and results in the first half of the year below the previous year in a challenging market environment
- 07.May.2024 PTA-News: Dr. Hönle AG: Markus Arendt takes up his position as CEO of Dr. Hönle AG
- 18.Apr.2024 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 27.Feb.2024 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 26.Feb.2024 PTA-News: Dr. Hönle AG: Hönle Group has a moderate start to the new financial year and confirms the outlook for the year as a whole
- 23.Feb.2024 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 23.Feb.2024 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 22.Feb.2024 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 22.Feb.2024 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 22.Feb.2024 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 15.Feb.2024 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 07.Dec.2023 PTA-News: Dr. Hönle AG: Hönle Group generated adjusted operating profit of €6.9 million in the 2022/2023 financial year
- 03.Nov.2023 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 20.Oct.2023 PTA-News: Dr. Hönle AG: Dr. Markus Arendt becomes Managing Director of Dr. Hönle AG
- 07.Aug.2023 PTA-News: Dr. Hönle AG: Hönle generated an adjusted operating result of €5.0 million in nine months
- 30.Jun.2023 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 12.Jun.2023 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 07.Jun.2023 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 07.Jun.2023 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 07.Jun.2023 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 07.Jun.2023 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 07.Jun.2023 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 12.May.2023 PTA-News: Dr. Hönle AG: Hönle generated an operating result of €3.7 million in the first six months
- 25.Apr.2023 PTA-News: Dr. Hönle AG: Change at the top of Dr. Hönle AG: Dr. Franz Richter becomes the new CEO
- 31.Mar.2023 PTA-News: Dr. Hönle AG: Dr. Franz Richter is the new Chairman of the Supervisory Board of Dr. Hönle AG
- 15.Feb.2023 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 17.Jan.2023 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 15.Dec.2022 PTA-News: Dr. Hönle AG: Planned change in the supervisory board of Dr. Hönle AG
- 09.Dec.2022 PTA-PVR: Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 19.Oct.2022 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 02.Sep.2022 PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 02.Sep.2022 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 05.Aug.2022 PTA-News: Dr. Hönle AG: Hönle Group increases sales by 12% in 9 months
- 16.May.2022 PTA-News: Dr. Hönle AG: Restructuring of the Management Board of Dr. Hönle AG
- 12.May.2022 PTA-News: Dr. Hönle AG: Hönle increases its operating result by 14% to € 7.7 million in six months
- 11.May.2022 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 31.Mar.2022 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 23.Mar.2022 PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
- 28.Feb.2022 PTA-PVR : Dr. Hönle AG: Correction of a Release according to article 40 para. 1 WpHG from 28.02.2022
- 28.Feb.2022 PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 24.Feb.2022 PTA-PVR : Dr. Hönle AG: Release according to Article 40, Section 1 of the WpHG
- 22.Feb.2022 PTA-News: Dr. Hönle AG: Hönle increases its operating result by 113.6% to € 4.5 million in the first quarter
- 26.Oct.2021 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 06.Aug.2021 PTA-News: Dr. Hönle AG: Sales increase in the 9-month period by 18.4% to EUR 84.9 million
- 01.Jul.2021 PTA-DD: Dr. Hönle AG: Managers’ transactions announcement according to article 19 MAR
- 12.May.2021 PTA-News: Dr. Hönle AG: Hönle increases its operating result by 16.4% to EUR 6.7 million in the first half of the year
- 22.Feb.2021 PTA-News: Dr. Hönle AG: Hönle achieves revenues of Euro 26.7 million and an operating result of Euro 2.1 million in the first quarter
- 12.Feb.2021 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
- 02.Dec.2020 PTA-News: Dr. Hönle AG: Hönle Group generates operating profit of EUR 8.1 million
- 01.Sep.2020 PTA-NVR: Dr. Hönle AG: Total Voting Rights Announcement according to Article 41 of the WpHG
- 18.Aug.2020 PTA-News: Dr. Hönle AG: Acquisition in the Life Science Sector
- 07.Aug.2020 PTA-News: Dr. Hönle AG: Hönle achieves operating result of Euro 6.3 million
- 15.May.2020 PTA-News: Dr. Hönle AG: Hönle Group generates operating result of 5.8 million euros
- 09.Jan.2020 PTA-AFR: Dr. Hönle AG: Pre-announcement of a financial report according to articles 114 – 117 WpHG
Adhoc Release
- 14.Sep.2025 PTA-Adhoc: Dr. Hönle AG: Dr. Markus Arendt to leave Management Board of Hoenle AG
- 05.Aug.2025 PTA-Adhoc: Dr. Hönle AG: Hoenle Group adjusts forecast for financial year 2024/25
- 21.Nov.2024 PTA-Adhoc: Dr. Hönle AG: Hönle Group confirms positive operating result for financial year 2023/24, but special effects impact EBIT
- 30.Apr.2024 PTA-Adhoc: Dr. Hönle AG: Adjustment of the outlook for the 2023/24 financial year
- 09.Feb.2024 PTA-Adhoc: Dr. Hönle AG: Hönle Group expects a decline in sales and earnings in Q1 and confirms outlook for the financial year
- 05.Dec.2023 PTA-Adhoc: Dr. Hönle AG: Hönle Group adjusts forecast for the 2022/2023 FY and provides outlook on the 2023/2024 FY
- 20.Oct.2023 PTA-Adhoc: Dr. Hönle AG: Dr. Markus Arendt becomes Managing Director of Dr. Hönle AG
- 01.Jun.2023 PTA-Adhoc: Dr. Hönle AG: Reassessment of the business situation and adjustment of the outlook for the 2022/2023 financial year
- 25.Apr.2023 PTA-Adhoc: Dr. Hönle AG: Dr. Franz Richter becomes CEO of Dr. Hönle AG
- 20.Feb.2023 PTA-Adhoc: Dr. Hönle AG: Hönle Group generates operating result of € 2.7 million in the first quarter and confirms the annual forecast
- 21.Dec.2022 PTA-Adhoc: Dr. Hönle AG: Special effects weigh on earnings in the 2021/2022 financial year
- 12.Dec.2022 PTA-Adhoc: Dr. Hönle AG: Hönle sells all shares in Raesch Quarz (Germany) GmbH, Ilmenau
- 02.Dec.2022 PTA-Adhoc: Dr. Hönle AG: Declining market for air sterilization devices leads to impairment of inventories at Hönle
- 02.Nov.2022 PTA-Adhoc: Dr. Hönle AG: Initiation of restructuring measures at Raesch Quarz (Germany) GmbH, Ilmenau
- 23.Aug.2022 PTA-Adhoc: Dr. Hönle AG: Norbert Haimerl becomes CEO of Dr. Hönle AG
- 29.Jul.2022 PTA-Adhoc: Dr. Hönle AG: Hönle achieves an operating result of € 7.2 million in the 9-month period
- 22.Jul.2022 PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG adjusts outlook for 2021/2022 financial year
- 18.Feb.2022 PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG puts annual forecast into concrete terms
- 01.Dec.2021 PTA-Adhoc: Dr. Hönle AG: Hönle Group generates adjusted operating profit of EUR 7.9 million
- 24.Nov.2021 PTA-Adhoc: Dr. Hönle AG: Hönle takes non-cash impairment into account in the 2020/2021 financial year – outlook remains positive
- 06.Oct.2021 PTA-Adhoc: Dr. Hönle AG: Hönle adjusts outlook for the past financial year and gives outlook for the new financial year
- 15.Jul.2021 PTA-Adhoc: Dr. Hönle AG: The promotion of mobile air disinfection systems provides excellent growth opportunities for Hönle
- 15.Sep.2020 PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG acquires UV-Technik Meyer GmbH
- 21.Aug.2020 PTA-Adhoc: Dr. Hönle AG: Dr. Hönle AG wins new strategic investor for growth financing
- 17.Aug.2020 PTA-Adhoc: Dr. Hönle AG: Hönle acquires Disinfection Specialist, STERILSYSTEMS
- 27.Apr.2020 PTA-Adhoc: Dr. Hönle AG: Hönle withdraws forecast due to the Covid-19 pandemic